Chemistry:Linerixibat
From HandWiki
Linerixibat, sold under the brand name Lynavoy, is a medication used for the treatment of cholestatic pruritus. Linerixibat is an ileal bile acid transporter (IBAT) inhibitor.[1]
Linerixibat was approved for medical use in the United States in March 2026.[2]
References
- ↑ "Ileal Bile Acid Transporter Inhibitors for Adult Patients with Autoimmune Cholestatic Liver Diseases: A Systematic Review and Meta-Analysis.". Gastroenterology Insights 16 (3): 30. August 2025. doi:10.3390/gastroent16030030.
- ↑ "Lynavoy (linerixibat) FDA Approval History". 20 March 2026. https://www.drugs.com/history/lynavoy.html.
 |  |
